In another meta-analysis published in PLoS One, it was shown that ACE inhibitors give rise to a more potent improvement of the homeostasis model assessment of insulin resistance (HOMA-IR) in comparison with ARBs among the long-term intervention and high blood pressure patients with diabetes mellitus subgroup [11]. The gene discussed is ACE; the disease is diabetes mellitus.